OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies
Haobing Wang, Ling Tang, Yingjie Kong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9115-9115
Open Access | Times Cited: 8
Haobing Wang, Ling Tang, Yingjie Kong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9115-9115
Open Access | Times Cited: 8
Showing 8 citing articles:
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 7
Green Synthesis and Characterization of Silver Nanoparticles Using Azadirachta indica Seeds Extract: In Vitro and In Vivo Evaluation of Anti-Diabetic Activity
Gauhar Rehman, Muhammad Umar, Nasrullah Shah, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1677-1677
Open Access | Times Cited: 15
Gauhar Rehman, Muhammad Umar, Nasrullah Shah, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1677-1677
Open Access | Times Cited: 15
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 13
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 13
Should CAR-T cell therapy be considered a standard of care for patients with refractory diffuse large B-cell lymphoma in second line treatment?
Lucía Pérez‐Lamas, José Sandoval-Sus, Julio C. Chávez
Expert Opinion on Biological Therapy (2025)
Closed Access
Lucía Pérez‐Lamas, José Sandoval-Sus, Julio C. Chávez
Expert Opinion on Biological Therapy (2025)
Closed Access
Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
H. N. Abramson
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15674-15674
Open Access | Times Cited: 8
H. N. Abramson
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15674-15674
Open Access | Times Cited: 8
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
M. Hassaan Rehman, Ariba Qaiser, Hassan Sardar Khan, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
M. Hassaan Rehman, Ariba Qaiser, Hassan Sardar Khan, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
